Polyclonal Multidrug ESBL-Producing Klebsiella pneumoniae and Emergence of Susceptible Hypervirulent Klebsiella pneumoniae ST23 Isolates in Mozambique
- PMID: 37760735
- PMCID: PMC10525843
- DOI: 10.3390/antibiotics12091439
Polyclonal Multidrug ESBL-Producing Klebsiella pneumoniae and Emergence of Susceptible Hypervirulent Klebsiella pneumoniae ST23 Isolates in Mozambique
Abstract
Globally, antibiotic-resistant Klebsiella spp. cause healthcare-associated infections with high mortality rates, and the rise of hypervirulent Klebsiella pneumoniae (hvKp) poses a significant threat to human health linked to community-acquired infections and increasing non-susceptibility. We investigated the phenotypic and genetic features of 36 Klebsiella isolates recovered from invasive infections at Hospital Central of Maputo in Mozambique during one year. The majority of the isolates displayed multidrug resistance (MDR) (29/36) to cephalosporins, gentamicin, ciprofloxacin, and trimethoprim-sulfamethoxazole but retained susceptibility to amikacin, carbapenems, and colistin. Most isolates were ESBLs-producing (28/36), predominantly carrying the blaCTX-M-15 and other beta-lactamase genes (blaSHV, blaTEM-1, and blaOXA-1). Among the 16 genomes sequenced, multiple resistance genes from different antibiotic classes were identified, with blaCTX-M-15, mostly in the ISEcp1-blaCTX-M-15-orf477 genetic environment, co-existing with blaTEM-1 and aac(3)-IIa in five isolates. Our results highlight the presence of polyclonal MDR ESBL-producing K. pneumoniae from eight sequence types (ST), mostly harbouring distinct yersiniabactin within the conjugative integrative element (ICE). Further, we identified susceptible hvKp ST23, O1-K1-type isolates carrying yersiniabactin (ybt1/ICEKp10), colibactin, salmochelin, aerobactin, and hypermucoid locus (rmpADC), associated with severe infections in humans. These findings are worrying and underline the importance of implementing surveillance strategies to avoid the risk of the emergence of the most threatening MDR hvKp.
Keywords: CTX-M-15; ESBL; K. pneumoniae; Mozambique; hypervirulent K. pneumoniae ST23; multidrug resistant.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Characteristics of Hypervirulent Klebsiella pneumoniae: Does Low Expression of rmpA Contribute to the Absence of Hypervirulence?Front Microbiol. 2020 Mar 17;11:436. doi: 10.3389/fmicb.2020.00436. eCollection 2020. Front Microbiol. 2020. PMID: 32256482 Free PMC article.
-
The Role of Plasmid and Resistance Gene Acquisition in the Emergence of ST23 Multi-Drug Resistant, Hypervirulent Klebsiella pneumoniae.Microbiol Spectr. 2022 Apr 27;10(2):e0192921. doi: 10.1128/spectrum.01929-21. Epub 2022 Mar 17. Microbiol Spectr. 2022. PMID: 35297657 Free PMC article.
-
Phenotypic and Genotypic Profiles of Extended-Spectrum Beta-Lactamase-Producing Multidrug-Resistant Klebsiella pneumoniae in Northeastern Thailand.Antibiotics (Basel). 2024 Sep 25;13(10):917. doi: 10.3390/antibiotics13100917. Antibiotics (Basel). 2024. PMID: 39452184 Free PMC article.
-
Emergence of Multidrug Resistant Hypervirulent ST23 Klebsiella pneumoniae: Multidrug Resistant Plasmid Acquisition Drives Evolution.Front Cell Infect Microbiol. 2020 Nov 20;10:575289. doi: 10.3389/fcimb.2020.575289. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33330125 Free PMC article.
-
The Brief Case: A renal abscess caused by ST35-KL108, a strain of multidrug-resistant hypervirulent Klebsiella pneumoniae.J Clin Microbiol. 2025 May 14;63(5):e0205724. doi: 10.1128/jcm.02057-24. Epub 2025 May 14. J Clin Microbiol. 2025. PMID: 40366136 Free PMC article. Review. No abstract available.
Cited by
-
Klebsiella in Wildlife: Clonal Dynamics and Antibiotic Resistance Profiles, a Systematic Review.Pathogens. 2024 Oct 30;13(11):945. doi: 10.3390/pathogens13110945. Pathogens. 2024. PMID: 39599498 Free PMC article.
-
Exploring AMR and virulence in Klebsiella pneumoniae isolated from humans and pet animals: A complement of phenotype by WGS-derived profiles in a One Health study in Egypt.One Health. 2024 Sep 27;19:100904. doi: 10.1016/j.onehlt.2024.100904. eCollection 2024 Dec. One Health. 2024. PMID: 39399229 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous